 | |||||
| lose weight | |||||
| NEWS | |||||
| Zealand's GLP-1/GLP-2 Drug Elicits Over 11% Weight-Loss—With the Potential for More Analysts at William Blair say dapiglutide's 11.6% weight reduction at 28 weeks could still be better, given that Zealand's study predominantly ...
| |||||
| See more results | Edit this alert | |||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
